HRTX

Heron Therapeutics, Inc. (HRTX), headquartered in San Diego, California, is a pioneering biotechnology firm committed to developing advanced therapies targeting critical unmet needs in pain management and antiemetic care. The company focuses on the research and commercialization of innovative pharmaceutical solutions designed to enhance the quality of life for patients undergoing surgical procedures and cancer treatments. With a strong pipeline and a strategic emphasis on high-demand therapeutic areas, Heron Therapeutics is uniquely positioned to drive meaningful advancements in healthcare, ultimately improving patient outcomes and addressing key challenges in the medical field.